Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
Recruiting · NCT05203328 · Interventional (participants receive a specific treatment) · Lead sponsor: The Cooper Health System
View the official record on ClinicalTrials.gov →Interventions studied
Regular nasal canulaVapotherm
What this trial is about
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- age\>18 years
- patient undergoing EBUS bronchoscopy with moderate conscious sedation.
Exclusion criteria
- subjects with previous nasal surgeries
- subjects with oxygen saturation \<90% on room air prior to procedure
- subjects who are pregnant
- subjects with known facial fractures or recent facial trauma
- subjects on any anticoagulation that cannot be discontinued prior to the procedure
Where it is running
1 location listed across 1 US state.
- Cooper University Hospital - Camden, New Jersey, United States